U.S. market Closed. Opens in 2 days 2 hours 22 minutes

FLGT | Fulgent Genetics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue289.21M618.97M992.58M421.71M32.53M21.36M18.73M18.28M9.58M1.28M
Cost of Revenue192.60M252.07M215.53M89.81M14.11M10.69M8.55M6.72M5.07M936.00K
Gross Profit96.61M366.90M777.05M331.90M18.42M10.66M10.18M11.55M4.51M342.00K
Operating Expenses171.91M185.40M101.10M41.75M18.85M15.72M13.66M10.64M9.52M1.33M
Selling, General & Admin130.47M149.99M75.17M30.17M12.31M10.19M9.44M7.08M5.09M811.00K
Research & Development41.44M28.91M24.22M11.58M6.54M5.53M4.22M3.56M4.43M521.00K
Other Operating Expenses7.84M6.50M1.71MN/AN/AN/AN/AN/AN/AN/A
Operating Income-75.30M178.53M675.95M290.16M-428.00K-5.06M-3.48M918.00K-5.01M-990.00K
Other Expenses / Income-98.79M5.50M1.35M1.53M837.00K434.00K481.00K-5.39M27.00KN/A
Before Tax Income-174.09M184.03M677.30M291.68M409.00K-4.62M-3.00M-4.47M-4.99M-990.00K
Income Tax Expenses1.15M42.10M174.79M72.53M43.00K-1.07M-1.01M920.00KN/AN/A
Net Income-167.82M143.40M507.36M214.31M366.00K-4.49M-2.51M-5.35M-8.31M-4.28M
Interest Expenses37.00M5.50MN/AN/AN/AN/AN/A5.39MN/AN/A
Basic Shares Outstanding29.78M30.10M29.41M22.69M18.71M17.98M17.74M17.68M12.35M12.77M
Diluted Shares Outstanding29.78M30.96M30.98M24.06M18.71M17.98M17.74M17.68M12.35M12.77M
EBITDA-43.54M190.97M677.66M290.16M-428.00K-5.06M-1.80M2.13M-7.74M-4.09M
EBITDA Margin-15.05%30.85%68.27%68.80%-1.32%-23.68%-9.59%11.65%-80.82%-319.80%
EBIT-129.67M191.00M682.16M286.84M409.00K-5.56M-3.52M960.00K-8.31M-4.28M
EBIT Margin-44.84%30.86%68.73%68.02%1.26%-26.02%-18.82%5.25%-86.82%-335.13%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙